Podcasts about Drug

This is our Week in Review of the Kouri Richins murder trial—and the prosecution's key witnesses are telling different stories under oath.Carmen Lauber testified she bought fentanyl for Kouri Richins four times before Eric died. Robert Crozier—the man who allegedly supplied those drugs to Lauber—took the stand and said something different. He testified he only sold oxycodone, not fentanyl, because "everybody was scared of fentanyl" at the time. He claimed he was "detoxing and out of it" during his original statement to detectives. Lauber herself admitted confusion under cross-examination.When your two central witnesses can't agree on what the drugs actually were, the prosecution has a problem.Former FBI behavioral analyst Robin Dreeke spent 21 years with the Bureau, including time as Chief of the Counterintelligence Behavioral Analysis Program. His career was built on reading people in high-stakes environments—separating truth from performance, assessing credibility under pressure. He examines what behavioral signals reveal whether a witness with credibility wounds is still telling core truth versus constructing a self-serving narrative. He also reads Kouri's sustained composure through five days of devastating testimony.Defense attorney Bob Motta breaks down whether the prosecution can recover. The state played a recording of Kouri calling the medical examiner's office asking detailed questions about substances found in Eric's body. But Bob analyzes whether that shows consciousness of guilt—or exactly what you'd expect from a widow trying to understand her husband's death.The most significant fact the jury has heard: the state's own former Chief Medical Examiner still lists Eric's manner of death as "undetermined." Not homicide. Four years later.Over twenty witnesses called. Fentanyl in Eric's system established. Financial problems documented. Boyfriend confirmed. But the prosecution still hasn't proven how fentanyl got into Eric or that Kouri administered it.Kouri Richins is presumed innocent until proven guilty.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#KouriRichinsTrial #EricRichinsMurder #CarmenLauberTestimony #RobertCrozier #RobinDreekeFBI #BobMottaDefense #FentanylCase #UtahTrial #TrueCrimePodcast #HiddenKillersPod

Wir haben uns einen unserer Lieblingsgäste eingeladen, um eine kontroverse Frage der Suchtszene zu diskutieren: Kann man nach einer Suchterkrankung wieder gesund werden oder bleiben wir für immer chronisch krank? Kurz und zugespitzt: Ist Sucht heilbar? Georg Schomerus ist Professor an der Universität Leipzig und Direktor der Klinik und Poliklinik für Psychiatrie und Psychotherapie am Universitätsklinikum Leipzig. Sein Spezialgebiet ist die Stigmaforschung – insbesondere die Stigmatisierung von Alkoholabhängigkeit. Wir sprechen heute mit ihm über die Bedeutung von Genesung und Krankheit, warum es hilfreich ist, Sucht als Spektrum anzusehen, und wieso Recovery ein sinnvolles Konzept sein kann.Quellen:Etwa drei Viertel der derjenigen, die die Diagnosekriterien für eine Alkoholabhängigkeit nach ICD-10 erfüllen, suchen nie eine Behandlung auf.John, U., et al., Langzeitverläufe der Alkoholabhängigkeit. Der Nervenarzt, 2025. 96(1): 31–36.85 Prozent aller Heranwachsenden, die zwischen 18 und 25 Jahren die Diagnosekriterien einer Alkoholabhängigkeit erfüllen, erfüllen diese Kriterien mit 30 Jahren nicht mehr. Seeley, J. R., et al., Prevalence, incidence, recovery, and recurrence of alcohol use disorders from childhood to age 30. Drug and alcohol dependence, 2019. 194: 45–50.Das Bild von Sucht als Spektrum reduziert stigmatisierende EinstellungenG. Schomerus, M.C. Angermeyer, S.E. Baumeister, S. Stolzenburg, B.G. Link, J.C. Phelan: An online intervention using information on the mental health-mental illness continuum to reduce stigma. In: Eur Psychiatry, 2016, 32, S. 21–27; PMID 26802980Dynamisches Modell von VerantwortungSchomerus, Georg; Corrigan, Patrick William. The Stigma of Substance Use Disorders (English Edition) (S.6). Cambridge University Press.Kannst du dir aber auch auf unserer Website anschauen. Da haben wir ein paar Grundlagen zum Thema Stigma leicht verständlich gesammelt. Das Bild von dem Modell findest du da auch:https://www.sodaklub.com/stigma “While re-addiction is clearly a hazard for some, others achieve a realistic and lasting confidence that they've outgrown their addictions and it's time to move on. In fact, survey research published over the last thirty years indicates that most addicts eventually recover permanently. For them, the disease label may be an unnecessary, even harmful, burden.” Mark Lewis – Why Addiction is not a disease (als Buch) oder als Paper: https://pubmed.ncbi.nlm.nih.gov/28725282/Unterstütze uns auf Steady:https://steadyhq.com/de/sodaklub/Mia GatowMias Buch: »Rausch und Klarheit«Mias Newsletter: Romanzen und FinanzenMika DöringRecovery Deutschland e.V. Mikas KunstRecovery Studiehttps://www.soscisurvey.de/recovery2/ Hosted on Acast. See acast.com/privacy for more information.

Are leg arteries ever "too small to treat"?   Around the world, many patients with Peripheral Artery Disease (PAD), especially those with below-the-knee and small vessel disease, are told their arteries are "too small" or "too distal" for intervention.   In this episode of The Heart of Innovation, hosts Kym McNicholas and Dr. John Phillips interview Dr. Naoki Hayakawa, Chief and Director of Endovascular Therapy at Asahi General Hospital in Japan.Dr. Hayakawa is internationally recognized for tackling the most complex chronic total occlusions (CTOs), including small-caliber below-the-knee vessels that others may consider untreatable.  He has served as a live demonstration operator at major international meetings including JET, CCT Peripheral, Kokura Live, and Peripheral CTO Seminars, and has published extensively on:  • IVUS-guided wiring techniques  • Below-the-knee chronic total occlusions  • Drug-coated balloon therapy  • Transradial approaches for complex PAD  • Advanced re-entry and retrograde access techniques   His work challenges outdated assumptions about what is and isn't possible in limb salvage.In this conversation, Dr. Hayakawa sets the record straight on:  • What can truly be treated in small vessel PAD  • When vessels are actually too small  • The importance of imaging and IVUS guidance  • Why patients must seek experienced operators for complex disease  • What global standards of care should look like  If you or someone you love has been told "nothing more can be done," this episode is essential viewing.   - Concerned about leg circulation or told your vessels are too small?Call the Leg Saver Hotline: 1-833-PAD-LEGSBecause "too small to treat" should never be the final answer without expert evaluation.   Subscribe to The Heart of Innovation for global leaders in vascular innovation, limb salvage, and PAD care.  #PeripheralArteryDisease#PAD#LimbSalvage#BelowTheKnee#ChronicTotalOcclusion#EndovascularTherapy#IVUS#CriticalLimbIschemia

Greg Brady spoke with Hank Idsinga, 640 Toronto's Crime Specialist and former police inspector about A central figure in the Project South bust has been ordered not to contact a man arrested in Ryan Wedding's alleged drug ring. Learn more about your ad choices. Visit megaphone.fm/adchoices

Why drug prices skyrocketed after the Affordable Care Act and what you can do about it. Order Sharyl's new bestselling book: “Follow the $cience.” Subscribe to my two podcasts: “The Sharyl Attkisson Podcast” and “Full Measure After Hours.” Leave a review, subscribe and share with your friends! Support independent journalism by visiting the new Sharyl Attkisson store.

If you're struggling with food addiction, emotional eating, binge eating, or the constant start-over cycle, this episode is going to challenge the way you think about recovery. Coach Mary shares a powerful truth about food sobriety that may feel uncomfortable — but could change everything about how you approach cravings, stress, and long-term weight loss.If you're ready to stop relying on willpower and start building real food freedom, this conversation is for you.Grab your copy of my FREE 9 page Beginner's Guide to Food Sobriety https://www.foodfreedomwithmary.com/foodsobrietyguideFood Freedom Online Course: https://www.foodfreedomwithmary.com/foodfreedomcourseFood Sobriety Mini Course -https://www.foodfreedomwithmary.com/foodsobrietymcWant to learn more about me and my coaching programs? Do you need private coaching and intensive daily contact with a coach? Fill out my application so we can chat about whether or not my program is for you and which option is best for you. Payment plans available. Don't see a payment option that works for your pay schedule? Let's chat about a custom pay plan.www.foodfreedomwithmary.com/chooseyourpath Join my online community The Food Freedom Tribe! An online community of support, eduction, inspiration, accountability….. Learn more here: https://www.foodfreedomwithmary.com/tribemembership Application: https://docs.google.com/forms/d/1upnWHYK0RXfmyRTqlsF_R06z3NA8LZYHIMWFykq7-X4/viewformInstagram: www.instagram.com/coachmaryroberts Facebook: www.Facebook.com/ketomary71 Facebook group: https://www.facebook.com/groups/4915319108493196/?ref=share_group_linkWebsite: www.foodfreedomwithmary.com Join the email list.Email: mary@foodfreedomwithmary.com

The prosecution's fentanyl supply chain just hit a major credibility problem in the Kouri Richins trial. Robert Crozier testified he only sold oxycodone to Carmen Lauber—not fentanyl—because "everybody was scared of fentanyl" at the time. That directly contradicts what Lauber told the jury. When your two drug-chain witnesses can't agree on what the drugs actually were, the entire theory starts to crumble.Tony Brueski and Robin Dreeke sit down with defense attorney Bob Motta to analyze the prosecution's mounting problems. Dr. Erik Christensen—the state's own former Chief Medical Examiner—admitted on the stand that Eric Richins' death certificate still lists manner of death as "undetermined." Not homicide. After four years of investigation, the man who performed the analysis can't definitively say this was murder.The jury heard a nine-minute recording of Kouri calling the medical examiner's office asking about fentanyl levels, how it might have been ingested, and the Seroquel found in Eric's system. The prosecution wants jurors to see consciousness of guilt. Bob Motta explains why the defense sees something entirely different—a grieving widow seeking answers about her husband's death.Motta analyzes the significance of the Midway property timeline, where Carmen Lauber claims she buried fentanyl in a fire pit during a window when the house sat vacant. He examines what the presence of "a lot" of Seroquel in Eric's blood might mean for the case. And he identifies exactly what the prosecution must accomplish in the remaining weeks to make their theory viable.No fentanyl has ever been found in the Richins home. The drug witnesses are contradicting each other. The medical examiner won't call it homicide. Is this case already in trouble?Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#KouriRichins #EricRichins #CarmenLauber #FentanylTrial #BobMotta #TrueCrime #HiddenKillers #UtahCourt #RobinDreeke #TonyBrueski

In this week's episode of Medicine: The Truth, hosts Jeremy Corr and Dr. Robert Pearl unpack a wide range of developments shaping healthcare in America today, including the TrumpRx drug discount program. From new legislation affecting telehealth and pharmacy benefit managers (PBMs) to the rapid spread of measles and growing public concern about vaccine policy, this month's discussion highlights the policy decisions and scientific debates influencing medicine right now. The episode opens with the latest federal legislation passed to avert a government shutdown. While healthcare was not the central focus of this particular political battle, the bill contains several provisions that affect medical practice. These include extensions for telehealth coverage and hospital-at-home programs, reforms targeting PBM transparency and new requirements designed to address “ghost networks” in Medicare Advantage provider directories. Dr. Pearl explains that while these provisions represent incremental progress, they are unlikely to solve the larger problems driving healthcare costs and access challenges in the United States. Here are the other major storylines from episode 104: Healthcare costs remain nation's top concern: A new KFF poll finds that healthcare expenses rank above food, housing and utilities as the economic issue Americans worry about most. Prior authorization frustrations grow: Many patients report delays or denials of care due to insurance requirements, highlighting persistent tension between insurers, physicians and patients. Drug pricing debates continue: Pearl examines a new prescription drug website initiative and explains why it may have limited impact compared with broader policy proposals such as “most favored nation” pricing. Telehealth's uncertain future: Although the latest legislation extends certain pandemic-era flexibilities, the lack of a permanent solution leaves virtual care programs in limbo. PBM reforms move forward slowly: New policies aim to increase transparency and reduce incentives tied to drug list prices, though Pearl notes that meaningful change will depend on future implementation. Site-neutral payment gains attention: A provision requiring unique identifiers for outpatient services could pave the way for policies that eliminate higher reimbursement for hospital-owned facilities providing identical care. Measles outbreaks surge: Nearly a thousand cases have already been reported in 2026, with the overwhelming majority occurring among unvaccinated children. Trust in the CDC declines: Polling shows confidence in the agency has dropped significantly following changes to vaccine recommendations. Independent vaccine review groups emerge: Medical organizations and states are forming new committees to evaluate vaccine evidence as federal guidance becomes more contested. Early colon cancer deaths rise: The death of actor James Van Der Beek at age 48 highlights the growing incidence of colorectal cancer among younger adults and the importance of earlier screening. FDA confusion over a new flu vaccine: The agency initially declined to review Moderna's mRNA-based flu vaccine before reversing course and agreeing to evaluate it ahead of the next flu season. Younger Americans face worsening health trends: New claims data suggest chronic disease is appearing earlier among millennials and Gen Z, driven by lifestyle factors and reduced connection to primary care. Wearable data reveal health disparities: Apple Watch data show significant differences in resting heart rates across states, reflecting variations in lifestyle, access to care and public health conditions. As the episode concludes, Dr. Pearl warns that growing political conflict around vaccines and biomedical research risks undermining public trust in science. The consequences, he argues, could shape American medicine for decades to come. Tune in for more fact-based analysis and discussion of the biggest stories in healthcare. * * * Dr. Robert Pearl is the author of the new book “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine. Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn The post MTT #104: TrumpRx, rising measles cases & the politics of vaccine science appeared first on Fixing Healthcare.

See omnystudio.com/listener for privacy information.

A coroner has today heard evidence of the fractured, drug-fuelled family life of a 10-month-old baby who died of severe head injuries in Auckland six years ago. Poseidyn Hemopo-Pickering was rushed to Hospital after being found unresponsive on a September evening in 2020. He was later moved to Starship Children's Hospital, where he passed away. In the Auckland Coroner's Court today, Poseidyn's mother, Filoi Hua-kau provided some insight into the family's life in the leadup to his death. Finn Blackwell reports.

Today we'll be talking about how the conflict in Iran is affecting Thai nationals and visitors, in greater ASEAN news Malaysia's Prime Minister Anwar is blaming zionists for a campaign to destabilize his administration, and a little later in more classic Thaiger fare, and influencer is seeking a full refund after a botched 400,000 baht nose job.

MEDICARE ADVANTAGE MINUTE:                                                                UNITED HEALTHCARE AND ELEVANCE ARE SHRINKING THEIR MEDICARE ADVANTAGE ROLLS! AN OUTDATED MEDICARE RULE (THE 3 DAY RULE) KEEPS SENIORS IN HOSPITALS LONGER THAN NECESSARY.                                                                          (Temporary irritation will be the repetitive use of the unfortunate term "senior") CORRESPONDENCE: Paula does not need her PDP anymore but needs help figuring out how to disenroll from it. Howard failed to read the ANOC (Annual Notice Of Change) warning him that the monthly premium would be increased to $105. Now he worries about negative ramifications in the event that he stops paying that outrageous premium. Contact me at: DBJ@MLMMailbag.com (Most severe critic: A+)                   Visit us on: BabyBoomer.ORG Inspired by: "MEDICARE FOR THE LAZY MAN 2026; SIMPLEST & EASIEST GUIDE EVER!" "MEDICARE ENROLLMENT GUIDE!" (Free download from site below) "MEDICARE DRUG PLANS: A SIMPLE D-I-Y GUIDE" For sale on Amazon.com. After enjoying the books, please consider returning to leave a short customer review to  help future readers. Official website: https://www.MedicareForTheLazyMan.com.

Hour 3 of the Chris Hand Show | Wednesday 03-04-26See omnystudio.com/listener for privacy information.

Vancouver Mayor Ken Sim continues to apologize for alleging city councillor Sean Orr was distributing drugs in the Downtown Eastside. Sim says he was given false information based on a photo he briefly looked at. CBC municipal affairs reporter Justin McElroy and former municipal affairs strategist Maria Dobrinskaya join host Michelle Eliot to discuss what happened.

Hub Headlines features audio versions of the best commentaries and analysis published daily in The Hub. Enjoy listening to original and provocative takes on the issues that matter while you are on the go.   0:24 - Doug Ford says he's opposed to harm reduction—so why is Ontario handing out millions of free crack pipes?, by Adam Zivo   8:01 - From rupture to rapture: The curious case of Carney's endorsement of Trump's war, by Rudyard Griffiths   This program is narrated by automated voices. To get full-length editions of popular Hub podcasts and other great perks, subscribe to the Hub for only $2 a week: https://thehub.ca/join/hero/   Subscribe to The Hub's podcast feed to get all our best content: https://tinyurl.com/3a7zpd7e (Apple) https://tinyurl.com/y8akmfn7 (Spotify) Watch The Hub on YouTube: https://www.youtube.com/@TheHubCanada The Hub on X: https://x.com/thehubcanada?lang=en   CREDITS: Alisha Rao – Producer & Sound Editor

Is kratom safe – or is it quietly becoming the next opioid crisis?In this quick-hit episode, Zac sits down with recurring medical contributor Dr. Michael McCormick, Chief Medical Officer at Release Recovery, to clear the air on one of the most polarizing substances in America right now: kratom.Marketed as a natural herbal supplement and sold openly at gas stations and smoke shops, kratom is used by millions for energy, focus, pain relief – and even to help curb opioid withdrawal.But inside treatment centers, doctors are seeing something very different.In this episode, we break down:What kratom actually is (and how it works in the brain)Why low doses act like a stimulant — and high doses act like an opioidWhether kratom withdrawal requires medical detoxWhy it's showing up more and more in addiction treatmentThe truth about “legal” substances and who is most at riskWhy some experts believe it should not be sold over the counterWe're not here to attack people who use it responsibly. We're here to speak to the 10–15% of people predisposed to substance use disorder – the ones who may not know the risk until it's too late.If you or someone you love is using kratom, this conversation could change how you think about it.Connect with Zachttps://www.instagram.com/zwclark/https://www.linkedin.com/in/zac-c-746b96254/https://www.tiktok.com/@zacwclarkhttps://www.strava.com/athletes/55697553https://twitter.com/zacwclarkIf you or anyone you know is struggling, please do not hesitate to contact Release Recovery:(914) 588-6564http://releaserecovery.com@‌releaserecovery

The decades-old prohibition against gun possession by illegal drug users went before the U-S Supreme Court for oral arguments -- the focus in this case questions marijuana use... and brings up questions on what qualifies someone as a drug user? Managing Editor with SCOTUSblog, Kelsey Dallas, about the case and what the courts are thinking leading into their decisions.

The moment people start praising you, it's tempting to start wearing masks—but Jesus warns that the most dangerous drug for any leader is the hunger for titles and the addiction to applause.#FULLTANKwithBroBo​ #FULLTANKwithBroBo2026​ #BoSanchez​ #AuthenticLeadership​ #NoMoreMasks​ #Matthew23​ #SpiritualMaturity​ #Humility​ #FaithInAction​ #TrulyRichMindset​ #Grace​ #Integrity​--- PS. Do you want to help spread God's love too? You can support my mission through Fulltank, the Prayer Room, and other ministries by becoming a partner at BuyMeACoffee.com/BrotherBoSanchez Together, we can reach more hearts for God!Support this podcast. Help me reach others by supporting this podcast.To support my mission work, click this link now! http://BuyMeACoffee.com/brotherbosanchez

The global medicine supply chain faces mounting strain from chronic generic drug shortages, geopolitical tensions, and heavy reliance on geographically concentrated manufacturing. Quality failures, pricing pressures, and opaque sourcing of key starting materials have exposed structural vulnerabilities that extend beyond routine disruptions to broader national security and public health risks. This episode is part one of a two-part series examining the root causes of these vulnerabilities and the structural changes needed to address them. In this series, we spoke with Ronald T. Piervincenzi, Ph.D., CEO of the U.S. Pharmacopeia, about how these risks emerged and what it will take to build a more resilient pharmaceutical supply chain. In part one, Piervincenzi explains why generic drug shortages and national security concerns are often conflated, how extreme price erosion is driving manufacturers out of the market, and what USP's data reveals about supply concentration, including the critical role of key starting materials sourced from countries like China and India. The conversation also dives into USP's new Resilience Center and the strategic role it will serve in improving supply chain security.

Drug use, merit of prayers, married priest and more on this Monday edition of Called to Communion with Dr. David Anders.

Our best wishes to the people of Mexico during these trying times. This episode is for informative and entertainment purposes only, in no way is the off topic podcast glorifying the people of this episode but rather trying to inform people around the world of what's been going on in the great nation of Mexico. Thank you ❤️

In this episode of TopMedTalk, hosted by Andy Cumpstey at the anaesthesia research meeting in Birmingham, we dive into drug allergy and its mislabeling with Louise Savic, consultant anaesthetist and NIHR doctoral researcher at Leeds Teaching Hospitals NHS Trust, UK, who specialises in drug allergy and peri-operative anaphylaxis, and Tom Abbott, clinical senior lecturer in anaesthesia and peri-operative medicine at Queen Mary University of London, UK, and a consultant anaesthetist whose research uses clinical epidemiology and trials to improve surgical outcomes and reduce peri-operative complications. The discussion highlights the vast disparity between true drug allergies and mislabeling, emphasizing that around 90-95% of penicillin allergy labels are incorrect. Dr. Savic shares her journey in drug allergy research, focusing on the perioperative setting, while Dr. Abbott discusses the linkage between antimicrobial prescribing and resistance. The talk covers results from the Sapphire Project, revealing the high incidence of mislabeled drug allergies and their associated increased postoperative risks. The episode also explores potential strategies for 'de-labeling' patients, the role of multidisciplinary collaboration, and the next steps in research and practice change. -- Join us at Evidence Based Perioperative Medicine (EBPOM) World Congress 2026 in London. Be part of a global conversation as clinicians from around the world gather between 7-9th July at the British Library in London. Three days of evidence-based perioperative medicine, global insights, and expert debate—featuring speakers including Michael Marmot and Ken Rockwood. Register here - https://ebpom.org/product/ebpom-world-congress-2026/

The bombing campaign in Iran has drawn in other countries. The U.S. and Israel are targeting Iran, but nations including UAE, Kuwait, Qatar and Saudi Arabia are coming under fire from Tehran. And Lebanon's Hezbollah is also playing a role — firing rockets at Israel, and drawing Israeli airstrikes. U.S. president Donald Trump says operations are likely to last four or five weeks. But, he hasn't ruled out hostilities lasting “far longer.”We have reports from the region, with correspondents on the ground in Amman, Jerusalem, and Washington.And: The Iranian Revolutionary Guard Corps is a designated terrorist organization in Canada. So why do so many Iranians here say they are being threatened by its members?Also: As of January, Ozempic is no longer protected by an exclusivity patent in Canada. That means other companies can make generics here. We look at how that process is going.Plus: Public service cuts in Nova Scotia, and more.

Recently released federal documents revealed that Jeffrey Epstein had been the subject of a previously undisclosed Drug Enforcement Administration investigation beginning in 2010 that examined potential drug trafficking and prostitution-related financial activity tied to the U.S. Virgin Islands and New York. The 69-page memo, heavily redacted and marked “law enforcement sensitive,” identified Epstein and more than a dozen others as targets within an Organized Crime Drug Enforcement Task Forces probe that reportedly remained active for years. Despite the scope suggested by the document, no drug trafficking charges were ever brought, prompting Sen. Ron Wyden to demand fuller disclosure and an explanation of why the investigation did not result in prosecutions.Separately, documents released under the Epstein Files Transparency Act included a photograph of Commerce Secretary Howard Lutnick standing with Epstein on Little St. James, Epstein's private Caribbean island. The image was initially made public within the Justice Department's online archive before being temporarily removed and later restored, raising questions about how Epstein-related records are curated and reviewed. The brief removal triggered bipartisan calls for clarification, with critics questioning the explanation that the image had been flagged under standard review procedures. Together, the disclosures added to broader concerns about transparency, oversight, and the handling of evidence connected to Epstein's network and associations.to contact me:bobbycapucci@protonmail.comsource:Senator calls for DEA to provide info on "incredibly disturbing" Epstein drug investigation - CBS NewsPhoto of Lutnick on Epstein's island removed from Justice Department files now restored - CBS NewsBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-moscow-murders-and-more--5852883/support.

--{ "Alan Watt on Midnight Rider with Mike Chambers"}-- Remembering Alan - Scotland, pipe and drums - War - Why is the U.S. birthrate plummeting? - What is Anthropic and why did Trump order agencies and companies with military contracts to stop using their technology? US and Israel strike Iran and kill their Supreme Leader. What is Chabad Lubavitch? - Culture creation - Science of empire making - Global Empire based on Free Trade - Rosicrucians - John Dee - King James. Hegelian Dialectic - Psychopath: runs on pure ego, will save ego at all costs, will rationalize everything - Deindustrialization of Britain - Amalgamation of Europe - Dominant Minority - Guardian class, Helpers, and “Its”. Television conditioning - Cartoons; loss of attention span. - American integration - CFR, Agenda 21 - Waking Up; authorized groups for followers, fronts, plants - Expectation of conflict and head-on resistance - Change is done in an Individual, not Groups. “Love” - Hollywood, Music - Getting above emotion to compassion - Stopping blaming ourselves - Eternal truths - Holy books, religion; Islam, Christianity - Good Shepherds, Sheep - Hinduism, Brahmanism; Creator and Destroyer. Blue to black police uniforms - Multi-Jurisdictional Task Forces - Advanced weaponry - Drug trade; Opium in China; Poppies in Afghanistan; Heroin in Marseilles, France - World Federation - Internationalism - Overpopulation Theory (from Elite) - Falling Birth-rates in Western countries.

Listen in as our expert panel reviews important concepts behind antimicrobial stewardship along with tips to help limit unnecessary antimicrobial use.Special guests:Madeline King, PharmD, MPH, BCIDPCo-Director, Outpatient Antimicrobial StewardshipCooper University Health CareAssistant Professor of MedicineCooper Medical School at Rowan UniversityMichael A. Deaney, PharmD, AAHIVPInfectious Diseases Clinical Pharmacy SpecialistDenver Health & Hospital AuthorityYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science University For the purposes of disclosure, Dr. Madeline King reports a relevant financial relationship with Shionogi (speakers bureau for cefiderocol).The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in January 2026.Use code mt1026 at checkout for 10% off a new or upgraded subscription.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources related to this podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Toolbox: Antimicrobial StewardshipAlgorithm: Investigating Possible Drug AllergyCE Course: Implementing Rapid Diagnostic TestingChart: Antibiotic Therapy: When Are Shorter Courses Better?Send a text*****

Recently released federal documents revealed that Jeffrey Epstein had been the subject of a previously undisclosed Drug Enforcement Administration investigation beginning in 2010 that examined potential drug trafficking and prostitution-related financial activity tied to the U.S. Virgin Islands and New York. The 69-page memo, heavily redacted and marked “law enforcement sensitive,” identified Epstein and more than a dozen others as targets within an Organized Crime Drug Enforcement Task Forces probe that reportedly remained active for years. Despite the scope suggested by the document, no drug trafficking charges were ever brought, prompting Sen. Ron Wyden to demand fuller disclosure and an explanation of why the investigation did not result in prosecutions.Separately, documents released under the Epstein Files Transparency Act included a photograph of Commerce Secretary Howard Lutnick standing with Epstein on Little St. James, Epstein's private Caribbean island. The image was initially made public within the Justice Department's online archive before being temporarily removed and later restored, raising questions about how Epstein-related records are curated and reviewed. The brief removal triggered bipartisan calls for clarification, with critics questioning the explanation that the image had been flagged under standard review procedures. Together, the disclosures added to broader concerns about transparency, oversight, and the handling of evidence connected to Epstein's network and associations.to contact me:bobbycapucci@protonmail.comsource:Senator calls for DEA to provide info on "incredibly disturbing" Epstein drug investigation - CBS NewsPhoto of Lutnick on Epstein's island removed from Justice Department files now restored - CBS News

Drug Allegations rock Vancouver City Hall: What It Means for Accountability and Trust (0:41) Sean Orr, COPE Vancouver City councillor B.C. Conservatives Choose a Leader: Can the Party Move to the Centre Without Splitting? (17:27) Plus, after Nine Years of NDP Rule, Is B.C.'s Business Community Drawing a Fiscal Line in the Sand? (26:09) Keith Baldrey, Global B.C Legislative Bureau Chief Surrey's $200M Arena Bet: Bold Vision or Risky Timing? (32:51) Linda Annis, Surrey First city councillor and mayoral candidate Mobility Scooters on Sidewalks: Safety Fix or Shifted Burden? (40:38) Paul Albrecht, Langley City councillor Learn more about your ad choices. Visit megaphone.fm/adchoices

Investigative journalist Mariana van Zeller joins Bobby to break down what it really takes to gain the trust of cartels operating in and around the U.S. and why no story is ever worth a life. She shares what she’s learned embedding with traffickers, how drugs move through America, and why the crisis isn’t just criminal, it's public health. They also dive into the psychology of scammers, from international fraud rings to headline-making con artists, and debate whether the people behind these crimes see themselves as villains at all. It’s a conversation about power, opportunism, corruption, and the uncomfortable truth about America’s role in fueling it all. Watch The BobbyCast on Netflix! Follow on Instagram: @TheBobbyCast Follow on TikTok: @TheBobbyCast See omnystudio.com/listener for privacy information.

Day four of the Kouri Richins murder trial brought the witness prosecutors have been building toward since the case began. Carmen Lauber, Kouri Richins' former housekeeper, testified under immunity that she purchased illicit drugs for Kouri four times in the weeks surrounding Eric Richins' death in March 2022.According to Lauber's testimony, the requests started with pain pills allegedly meant for an investor and escalated to fentanyl. Lauber says she told Kouri the pills were fentanyl and that Kouri told her to go ahead and get them. Cash was left in a house Kouri was flipping. Pills were dropped in a firepit. The system, as Lauber described it, was designed to keep Kouri at a distance from every handoff.The most damaging testimony may have been what allegedly happened after Eric died. According to phone records displayed in court, Kouri texted Lauber three days after her husband's death asking if she still had her connection. She paid for the purchase with a check disguised as a cleaning payment. And when Lauber says she confronted Kouri about whether the pills had been for Eric, Kouri allegedly told her he died from a brain aneurysm.The defense landed significant blows on cross. Lauber tested positive for meth throughout the period of the alleged deals, initially told investigators Kouri asked for oxycodone rather than fentanyl, and confirmed that a recorded meeting with investigators included the instruction to provide details that would ensure a conviction. Her drug source, Robert Crozier, has also changed his account of what he sold her.Earlier in the day, toxicology testimony confirmed five times the lethal dose of illicit fentanyl in Eric's blood. No hydrocodone was detected. The jury also heard about phones belonging to Kouri's alleged boyfriend that were initially reported broken but later became operable and were processed by the FBI.Kouri Richins has pleaded not guilty to all charges and is presumed innocent. Cross-examination continues Friday.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#KouriRichins #RichinsTrial #CarmenLauber #EricRichins #TrueCrimeToday #FentanylMurder #SummitCountyTrial #TrueCrime #ParkCity #TrialUpdate

The Kouri Richins trial brings Carmen Lauber, Former Richins' Housekeeper, to the stand in this segment.The Kouri Richins murder trial continues in Utah as the state prosecutes the children's book author for allegedly poisoning her husband Eric Richins with fentanyl. Prosecutors allege she killed him for insurance money after secretly increasing his policy to $1.9 million. The defense maintains Eric died from accidental drug use.True Crime Today delivers real-time trial coverage as it happens—key testimony, critical cross-examinations, and the moments that matter. No waiting for nightly recaps. Watch the case unfold live.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#KouriRichins #KouriRichinsTrial #TrueCrimeToday #LiveTrial #EricRichins #UtahCourt #TrueCrimeNews #CourtTV #TrialWatch #BreakingCrime

This interview is disseminated on behalf of GT Biopharma. GT Biopharma (NASDAQ: GTBP) recently received approval from the U.S. Food and Drug Administration (FDA) for a new investigational drug trial for the solid tumor cancer treatment GTB-3650, as the race to develop a cure for cancer intensifies and the solid tumor market grows to $362 billion.Executive Chairman and Chief Executive Officer Michael Breen shares more details about the company's expectations and success indicators for the basket trial of the new medication, as well as upcoming milestones for 2026.Explore GT Biopharma: https://www.gtbiopharma.com/Watch the full YouTube interview here: https://youtu.be/VtISaFICJ5gAnd follow us to stay updated: https://www.youtube.com/GlobalOneMedia

Recently released federal documents revealed that Jeffrey Epstein had been the subject of a previously undisclosed Drug Enforcement Administration investigation beginning in 2010 that examined potential drug trafficking and prostitution-related financial activity tied to the U.S. Virgin Islands and New York. The 69-page memo, heavily redacted and marked “law enforcement sensitive,” identified Epstein and more than a dozen others as targets within an Organized Crime Drug Enforcement Task Forces probe that reportedly remained active for years. Despite the scope suggested by the document, no drug trafficking charges were ever brought, prompting Sen. Ron Wyden to demand fuller disclosure and an explanation of why the investigation did not result in prosecutions.Separately, documents released under the Epstein Files Transparency Act included a photograph of Commerce Secretary Howard Lutnick standing with Epstein on Little St. James, Epstein's private Caribbean island. The image was initially made public within the Justice Department's online archive before being temporarily removed and later restored, raising questions about how Epstein-related records are curated and reviewed. The brief removal triggered bipartisan calls for clarification, with critics questioning the explanation that the image had been flagged under standard review procedures. Together, the disclosures added to broader concerns about transparency, oversight, and the handling of evidence connected to Epstein's network and associations.to contact me:bobbycapucci@protonmail.comsource:Senator calls for DEA to provide info on "incredibly disturbing" Epstein drug investigation - CBS NewsPhoto of Lutnick on Epstein's island removed from Justice Department files now restored - CBS NewsBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-epstein-chronicles--5003294/support.

Justin talks to Michael P. Brady, Administrator for the Laborers' Local 157 Benefit Funds in Schenectady, NY about his fund's journey in covering GLP-1 drugs for weight loss and what other organizations can learn from his experience. Micheal is also a long-time member and volunteer with the International Foundation. He has served on the Health Care Management Committee and has spoken at many IFEBP conferences.

Pink Sheet Executive Editor Derrick Gingery, Editor-in-Chief Nielsen Hobbs and special guest Dave Wallace, executive editor of Generics Bulletin, discuss the generic industry's future direction and priorities (:27) and the impact of recent policy moves on the biosimilar industry (12:28) following their trade association's annual meeting, as well as US Food and Drug Administration Commissioner Martin Makary's comment on compassionate use and the concern it may have caused industry (20:23). More On These Topics From The Pink Sheet The State Of The Off-Patent Union: AAM's Murphy Sets Out US Achievements And Obstacles: https://insights.citeline.com/pink-sheet/biosimilars-and-generics/the-state-of-the-off-patent-union-aams-murphy-sets-out-achievements-and-obstacles-in-us-IHJH2CZBX5GGTI6UJQVE2WO2G4/ ‘Biology Is Dirty': HHS's Principal Deputy Counsel On How Biosimilar Firms Can Help US FDA: https://insights.citeline.com/pink-sheet/biosimilars-and-generics/biosimilars/biology-is-dirty-hhss-principal-deputy-counsel-on-how-biosimilar-firms-can-help-us-fda-2GEAUSXNMRCYNIXPS7P6IAYESE/ Makary's Compassionate Use Comments, Later Clarified, Still May Startle Industry: https://insights.citeline.com/pink-sheet/rare-diseases/makarys-compassionate-use-comments-later-clarified-still-may-startle-industry-XPBVZ6MH7FC7JKP2XEL4ZESWSE/

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper by Taylor et al. where authors report the effects of UPA and ADA on pain in patients with active RA or PsA stratified by inflammatory status, and a paper by Sonomoto et al. which shows the effectiveness of TOF, BAR, UPA and FIL in patients with RA.

Hey, first! We’re looking for your help. Can you take a couple minutes and fill out our Audience Survey? We’re dying to know more about the community that’s using this show — and about what’s working for you and what you’d like to see. Let us know! Today we’re switching it up. We’re sharing an episode from the new podcast Drug Story. In each episode, science journalist and self-described “public health nerd” Thomas Goetz goes deep on the story of a single drug — what it treats, how it came to be, and what it reveals about the business of health and disease. On this episode: the EpiPen, a device you’ll find in classrooms, on airplanes, in glove compartments — basically everywhere — because the EpiPen can be a literal life-saver for people with severe allergies. And of course, the EpiPen is also one of the most infamous examples of pharmaceutical profiteering gone bananas. That part of the story makes us especially geeked to share this episode. And there are more threads here — on the drug’s discovery, on the science of severe food allergies, and on what researchers have learned about preventing them — that Goetz does a great job of weaving together. If you like it, new episodes of Drug Story come out every week. We’ll be back with more Arm and a Leg in a few weeks. Meanwhile, don’t forget to help us by filling out our quick survey. Here’s a transcript of this episode. Send your stories and questions. Or call 724 ARM-N-LEG. Of course we’d love for you to support this show.See omnystudio.com/listener for privacy information.

Let us chat about today the inches all around us and also about how there is no market in healthcare all at once in this show. Today I am talking with Ivana Krajcinovic. And let me give you some examples of the inches. Two members of a plan get infusions at a hospital. And if these two members had gone down the street to get their infusions, the total cost of the two of them would have been $1 million less … $1 million less! How many inches is a million dollars? For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. Or the examples Ivana Krajcinovic talks about coming up where an independent practice was charging $135 for a chemo infusion and the hospital down the street was charging for the same exact drug, by the way—the same exact infusion—$13,560 … $135 versus $13,560! We talk about affordability in this country? Member's paying coinsurance off that 13K, by the way. And if you're doing the math at home, that is a 10,000% markup. Or if we start from the Medicare price, it was a 40,000% markup. Then there's another example that Ivana talks about where a plan member went to a hospital and got a $90,000 bill for a series of infusions that, again, down the street would have been $185—all in. Inches much? So, it's pretty clear why the show is part of "The Inches Are All Around Us" series. Why do I say this is part of the "No Market" series? Because look, functioning markets rationalize prices. That's just what they do. So, if you have two places in the exact same geography and one of them is charging 500 times or whatever the other one, you don't have a market if they're both still in business a year later. Ongoing wild price variations is a big tell that there's no market to be had. Another tell, though, is that carrier networks, who are supposed to be the demand curve here—or at least that's what their marketing says or what we are all kind of led to believe—they advertise as high-value networks, right? The fact that any given network experiences essentially no business repercussions for spending a million dollars extra of its plan sponsors' (its customers') money—because that's who's paying for this, the self-insured employer or union, at the end of the day—and the network, the carrier network doesn't lose business as a result … Right? Listen to the show from last week with Jacob Asher, MD (Take Two: EP398) about the carrier nonmarket and why this is the case. But bottom line, if anyone is waiting on a market to constrain prices for them, that is very magical thinking. Where this whole thing is gonna wind up, by the way, is with my guest today, Ivana Krajcinovic, suggesting a roadmap to make a whole lot more likely that you'll pay $135 for an infusion instead of 13 grand. For more on this, do go back and listen to the show with Keith Hartman, RPh, by the way. We teed this off a couple of years ago. That was episode 369. But in Ivana's upcoming roadmap that you're gonna hear about (just doubling down on the spoilers—if I'm gonna do something, I might as well do it well), but in that roadmap, direct contracts with indie practices will feature a starring role. I'm telling you this because if you're one of those folks that listens to like 23 minutes of any given podcast and then bails, make sure you make it to around the 30-minute mark of the show. As I have said several times already, my guest today is the incomparable Ivana Krajcinovic, the outgoing vice president of healthcare delivery at UNITE HERE HEALTH. Ivana has just retired, but she spent over three decades with her team protecting the health and the hard-earned wages of 230,000 hospitality workers. She is exactly the kind of "dangerous expert" that we love to have on the show—someone with the wisdom about how the system actually works and the articulate willingness to talk about it. Okay … so, this conversation about the inches and the nonmarket for infusions specifically in this country, for more information, do go back and read the really excellent Bloomberg News exposé by John Tozzi. It's a really good article, and you'll see everything that we talk about today in writing with all the fact-checking that one would expect from Bloomberg News. So, okay … what we'll do in this episode is, first, we're gonna talk about the infusion nonmarket, the inches and its implications, such as an infusion costing 500 times Medicare when there are 1.5x Medicare options in the same exact health system. Sometimes I just can't even with some of this stuff. But another nonmarket tell, again, is that carrier networks are still in business. We talk all about that. What happens next in this episode is we deconstruct the roadmap that Ivana used to fight back, which starts with (no surprises) drilling into data and ends with direct contracting with independent doctors. And how that happens is by carving out utilization management so that there is site-of-care steerage. So, this is a conversation about fiduciary duty. It's a conversation about transparency, the power of collective action. This podcast is sponsored by Aventria Health Group with an assist from Payerset. And I thank Payerset very much for the financial support. Also mentioned in this episode are UNITE HERE HEALTH; Jacob Asher, MD; Keith Hartman, RPh; Stan Schwartz, MD; ZERO.health; John Tozzi; Aventria Health Group; Payerset; Cora Opsahl; 32BJ Union Health Fund; Jonathan Baran; Peter Hayes; Erik Davis; Autumn Yongchu; Brian Cotter; Bright Spot Insights; John Quinn; Mark Newman; Nomi Health; Preston Alexander; Health Here; Ann Lewandowski; HealthCheck360; Sam Flanders, MD; Shane Cerone; Kada Health; and Cristin Dickerson, MD. For a list of healthcare industry acronyms and terms that may be unfamiliar to you, click here.   You can learn more at uhh.org and by connecting with Ivana on LinkedIn.   Ivana Krajcinovic, PhD, recently retired as vice president for healthcare delivery at UNITE HERE HEALTH (UHH), a national Taft-Hartley Fund that purchases healthcare for over 200,000 unionized hospitality workers and their families. Combining her training as a health economist with more than 30 years working directly with immigrants and the working poor, Ivana oversaw a wide variety of projects. She has deep expertise in engaging participants, ranging from benefit education to chronic disease self-management, as well as in developing peer-to-peer programs. Ivana led a team whose challenge was to radically bend the cost curve while maintaining quality coverage as every dollar that UHH spends on healthcare is a dollar that could go to a worker in wages—higher wages that are likely to do more for workers' health than increasing spending on their healthcare. Ivana and her team have utilized narrow networks, value-based contracts, and direct contracting and have established health centers designed for their members. Ivana has a PhD in economics from Yale University and is the author of From Company Doctors to Managed Care: The United Mineworkers' Noble Experiment (Cornell University Press).   00:00 $135 vs $13,560: How infusion drug prices play into the "Inches All Around Us" series. 02:02 How infusion drug pricing fits into the "No Market" series. 03:19 A roadmap and more episodes on this topic. 04:36 Introducing this week's expert, Ivana Krajcinovic, PhD. 05:10 A must-read Bloomberg News article on infusion pricing. 05:33 An overview of what to expect from this episode. 06:54 The first tell of the infusion nonmarket. 07:41 The price variations that Ivana has seen in the infusion nonmarket. 11:39 How hospital spend affects wage increases affects patients and employees twice over. 12:04 EP373 with Cora Opsahl. 13:43 The second tell of the infusion nonmarket. 14:33 Take Two: EP398 with Jacob Asher, MD. 14:55 EP483 with Jonathan Baran. 16:15 Why networks are apathetic to this pricing discrepancy. 17:55 The factors that play into the nonmarket issue of infusion drug pricing variations. 18:26 EP475 with Peter Hayes. 19:18 EP370 with Erik Davis and Autumn Yongchu. 19:45 Are pricing discrepancies easy to spot? 22:38 Where we have power in a nonmarket situation. 23:22 A recap of the advice in the show so far. 23:39 EP493 with John Quinn. 23:41 EP496 with Mark Newman. 25:51 How you place pricing pressure on an entity. 28:47 EP482 with Preston Alexander. 29:34 How an improved market creates time for better care coordination. 30:52 EP486 with Stan Schwartz, MD. 33:23 The fourth part of the roadmap. 36:41 EP492 and EP490 with Sam Flanders, MD, and Shane Cerone. 36:49 Why serving the community and being fiscally responsible should go hand in hand. 38:05 EP500 with Stacey.   You can learn more at uhh.org and by connecting with Ivana on LinkedIn.   Ivana Krajcinovic, PhD, discusses #infusion #drugpricing on our #healthcarepodcast. #healthcare #podcast #financialhealth #commericalpayermarketplace #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Dr Jacob Asher (Take Two: EP398), Stacey Richter (EP500), Dr Jay Kimmel, Mark Noel, Gary Campbell (Take Two: EP341), Zack Kanter, Mark Newman, Stacey Richter (INBW45)

Chris and Hector break down a headline that made it sound like the FBI was running a dark web drug market and separate rumor from reality. They revisit how confidential sources actually work, the fallout from past undercover operations, and why media framing matters. The conversation then shifts to zero click exploits sold to foreign actors, the risks behind LinkedIn identity verification, and a security researcher who found a simple but devastating vulnerability only to be threatened by lawyers. Join our Patreon for weekly bonus episodes: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.patreon.com/c/hackerandthefed⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Send HATF your questions at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠questions@hackerandthefed.com

There were more than 70,000 cases of alleged drug use during pregnancy sent to law enforcement officials across 21 states over six years, including Oregon. As reported in The Marshall Project, these cases involved unreliable drug tests that show inaccurate results, are difficult to read or are simply wrong. In Oregon, and in 12 other states, welfare agencies automatically report any positive test result to authorities. Shoshana Walter is a staff writer for The Marshall Project and reported on this trend with Jill Castellano. Walter joins us to share more on these tests.

-Matt Welch's Caribbean identity crisis at Da Pig Beach-The State of the Union aka a two-hour hostage note-A greatest hits, lowest lights compilation for President Camacho-The futility of “speeching” your way through a math-defying approval rating-You can't talk your way through a 38% approval rating-Let the hockey boys drink-Dan Crenshaw is allowed to be mad-The RNC's new guard of real fucking bozos and sycophantic dick-tots-JD Vance as anti-corruption czar and populist beard for the crypto-regime-Tariffs and The Gilded Age corruption engine, now with “ballroom fund” exclusions-Drug prices are down 600%,….so do you owe me money?-Moynihan screaming drug questions at his glitching phone-Marxist Republicans and the gobbledygook of corporate housing bans-Maybe let's just abolish the State of the Union-Dispatches from the Purple State: An interview with Senator Elissa Slotkin-Stop kicking allies in the teeth to play grab-ass with dictators-Walking out on Lindsey Graham's Danish disdain-AI thinks Moynihan is a neo-folk neo-Nazi-Four years of war and Ukraine gets a one-sentence hand wave-Anthropic vs. Hegseth: Code is speech until the Pentagon wants a frictionless kill-switch-We tried collectivism once. Everyone starved. The end.-Gemini identifies the mystery caller as Friedrich Nietzsche, chimney sweep-About that BBC BAFTA N-Word Drama….-“You're acting like Israel” is the ultimate Park Slope breakup trump cardPrefer to watch & chat live with other members of the Fifdom? This episode premieres over on our YouTube channel NOW.The Fifth Column (A Podcast) is a reader-supported publication. To receive new posts and support our work, consider becoming a free or paid subscriber.Follow The Fifth ColumnYouTube: @wethefifthInstagram: @we.the.fifthX: @wethefifthTikTok: @wethefifthFacebook: @thefifthcolumn This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.wethefifth.com/subscribe

Learn more about your ad choices. Visit megaphone.fm/adchoices

Christian Carmona grew up in Medellín's infamous Barrio Antioquia—an area known for prostitution, gambling, and later, cocaine. In this episode, Christian tells the inside story of a Colombian cocaine dynasty that quietly expanded from Medellín to Miami… and even Portland, Oregon. Raised “Americanized” in the suburbs, Christian didn't learn the truth about his father's criminal enterprise until federal agents came crashing down in 1991—taking both of his parents at once. From cartel-era Miami strategies (stash houses, mules, low-profile living) to family-wide trafficking ties and the chaos of the early 90s, Christian lays out how the business really worked behind the scenes. The story gets even wilder when Christian later gets pulled back into the orbit of his father's old associates—working at a bank where traffickers allegedly used safety deposit boxes to stash cash and kilos. A setup, a sting, and years of court delays later, Christian describes spending nearly four years incarcerated while prosecutors tried to force him to cooperate. This is a raw conversation about family, loyalty, survival, and redemption—plus how Christian found faith and wrote his book Zeal while locked up.

Follow Dave & Mahoney everywhere:Instagram: @daveandmahoneyTikTok: @daveandmahoneyFacebook: @daveandmahoneyYouTube: @daveandmahoneyAgree? Disagree? Want to yell at us?Voicemail: 833-YO-DUMMY Additional Content: daveandmahoney.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Nemesio Osegura Cervantes – known as 'El Mencho', head one the most important criminal organisations in Mexico, was killed by Mexican security forces on Sunday. Following his death, violence erupted across a number of Mexican states leading to the death of at least 74 people and over 9,500 troops have been deployed across the country in response to the violence. President Claudia Sheinbaum has said that normality has returned, but several foreign governments are still warning against travel to some states.Find a transcript and worksheet at: https://www.bbc.co.uk/learningenglish/english/features/learning-english-from-the-news_2026/260225Try Our World in English - BBC documentaries adapted in simple English: https://www.bbc.co.uk/learningenglish/english/features/our-world-in-englishFind out about our latest programmes. Subscribe to our email newsletter: https://www.bbc.co.uk/send/u178220599

Drug lord Nemesio Oseguera, known as “El Mencho,” was killed in a military raid in Mexico over the weekend. Laura Gottesdiener of Reuters explores how the operation went down. President Trump wasted no time imposing a new global tariff after the Supreme Court struck down his previous ones. Courtenay Brown of Axios joins to discuss what comes next for businesses and consumers. The Winter Olympics concluded Sunday night, and it was a pretty good showing for Team USA overall. The Athletic’s Matt Futterman explains how a series of injuries and other mishaps kept the Americans from a historic performance. Plus, authorities shot and killed a man after he breached the perimeter at President Trump’s Mar-a-Lago estate, New York braced for another big snowstorm, and how Punch the orphaned macaque captured the internet’s heart. Today’s episode was hosted by Yasmeen Kahn.

Gregory Zuckerman profiles Moderna CEO Stephane Bancel and the pivotal mRNA research by Kariko and Weissman, noting the company's difficult transition from drug therapies to vaccines. 2

This episode covers: • Microplastics Are Destroying Male Fertility and Metabolism New research is putting microplastics in a category most men still are not taking seriously: direct reproductive and hormone risk. A 2024 study detected microplastics in every human testicle examined, with polyethylene and PVC among the most common polymers. PVC is especially relevant because it's often tied to chemical additives that can disrupt endocrine signaling. The broader body of evidence points to micro- and nanoplastics crossing barriers like the blood–testis barrier, driving inflammation and oxidative stress in the testes, and showing associations with impaired sperm quality and hormone disruption. The longevity move here is reducing overall load: better water filtration, less plastic food contact, no heating food in plastic, fewer packaged foods, and taking indoor dust and air quality seriously, especially for men thinking about fertility now or hormone resilience over decades. • Sources: – Study (PubMed): https://pubmed.ncbi.nlm.nih.gov/38745431/ – Coverage: https://people.com/microplastics-in-every-human-testicle-infertility-8651215 • Fear of Aging Is Linked to Faster Biological Aging A new study ties aging anxiety to measurable acceleration in biological aging using DNA methylation clocks. People who reported more worry and negative beliefs about aging showed faster epigenetic aging signals, and the molecular differences clustered around stress and inflammatory pathways. In plain terms, chronic threat-mode thinking around aging maps onto biology that looks older on the clocks. For a longevity audience, this is a practical reminder that mental inputs affect physiological outputs. If your day-to-day mindset is constant pressure and decline narratives, that can show up downstream in stress biology and inflammatory tone. A smarter play is building a longevity framework around function, strength, purpose, and community, alongside the usual pillars like sleep, training, and metabolic health. • Source: https://medicalxpress.com/news/2026-02-older-links-health-faster-epigenetic.html • Additional source: https://www.nyu.edu/about/news-publications/news/2026/february/aging-anxiety.html • Retatrutide, the Triple-Agonist Weight-Loss Drug Pushing Bariatric-Level Results Retatrutide is a triple agonist that targets GLP-1, GIP, and glucagon receptors, and the weight-loss numbers being reported are massive. In a 68-week study in people with obesity and knee osteoarthritis, the highest dose group averaged about 28.7% body-weight loss, along with meaningful improvements in knee pain and function. This is the next phase of incretin medicine: multi-agonist drugs that can move body weight by a quarter or more. For biohackers, the performance and longevity angle is implementation: preserving lean mass through resistance training, hitting protein targets, monitoring micronutrients, and building a maintenance plan that doesn't collapse the moment the drug stops. The upside is cardiometabolic risk reduction at scale. The key is running it with structure. • Sources: – Eli Lilly release: https://investor.lilly.com/news-releases/news-release-details/lillys-triple-agonist-retatrutide-delivered-weight-loss-average – Coverage: https://nypost.com/2026/02/18/health/people-dropped-out-of-retatrutide-trial-for-losing-too-much-weight/ – Background: https://news.harvard.edu/gazette/story/2026/02/whats-next-for-glp-1s/ • AI Can Predict 130 Diseases From a Single Night of Sleep Stanford's SleepFM project shows how much long-horizon health information is encoded in sleep. Researchers trained a foundation model on roughly 585,000 hours of clinical polysomnography data from about 65,000 people. From a single night of sleep study signals, the model could estimate risk for 130 conditions, including dementia, heart attack, heart failure, chronic kidney disease, stroke, atrial fibrillation, and all-cause mortality, and it generalized across cohorts better than simple demographic baselines. The big implication is that sleep architecture and micro-patterns (stage distribution, fragmentation, breathing stability, micro-arousals) function like a dense biomarker stream for systemic aging and disease risk. Expect better sensors and more validated risk dashboards over time. Right now, this is another reason to treat sleep as a core diagnostic pillar, not just a recovery habit. • Sources: – Stanford Medicine: https://med.stanford.edu/news/all-news/2026/01/ai-sleep-disease.html – Paper (Nature Medicine): https://www.nature.com/articles/s41591-025-04133-4 • Living at High Altitude May Protect Against Diabetes by Turning Red Blood Cells Into Glucose Sinks For years, population data has suggested lower diabetes rates at higher elevations. New mechanistic work is pointing to a surprising driver: red blood cells changing how they handle glucose under low oxygen conditions. In hypoxia, red blood cells can behave like glucose sinks, pulling more sugar out of circulation and improving glucose tolerance, which may help explain the protective association seen at altitude. The downstream potential is a new class of altitude-mimetic approaches that target erythrocyte metabolism as a glucose lever, separate from appetite suppression or classic diabetes pathways. For biohackers, it expands the metabolic toolkit and reinforces that oxygen environment and blood physiology matter more than we've given them credit for. • Source: https://medicalxpress.com/news/2026-02-red-blood-cells-sugar-high.html • Dietary Supplement Regulatory Uniformity Act and the Future of Supplement Access A proposed bill is aiming to stop states from layering extra rules on dietary supplements beyond federal law, creating one national standard instead of a patchwork of state-by-state restrictions. Industry groups are supporting it as a way to reduce confusion and compliance chaos, especially as some states explore age limits or special labeling requirements for certain supplement categories. The strategic implication for biohackers is that regulation shapes access. Uniformity can stabilize availability, but it also raises the stakes of federal decisions on controversial ingredients. This is one of those policy stories that quietly determines what stays on shelves, what disappears, and how much innovation survives in the supplement space. • Sources: – NutritionInsight: https://www.nutritioninsight.com/news/npa-crn-supplements-us-fda-legislation.html – Congressional release: https://langworthy.house.gov/media/press-releases/congressman-langworthy-introduces-dietary-supplement-regulatory-uniformity-act – NutraIngredients: https://www.nutraingredients.com/Article/2026/02/05/new-bill-aims-to-end-state-supplement-regulations/ All source links are provided for direct access to the original reporting and research. New episodes every Tuesday, Thursday, Friday, and Sunday. Keywords: microplastics male fertility, microplastics testosterone decline, blood–testis barrier toxins, endocrine disruption plastics, sperm count microplastics, epigenetic age acceleration, fear of aging methylation, biological aging mindset, stress inflammation aging, retatrutide triple agonist, GLP-1 GIP glucagon weight loss, incretin drugs obesity treatment, muscle preservation on GLP-1, SleepFM AI model, sleep disease prediction, polysomnography risk scoring, dementia risk sleep data, altitude diabetes protection, hypoxia glucose metabolism, red blood cells glucose uptake, altitude mimetic therapy, Dietary Supplement Regulatory Uniformity Act, supplement regulation federal preemption, FDA supplement policy, biohacking news longevity, metabolic health optimization Thank you to our sponsors! - HeartMath | Go to https://www.heartmath.com/dave to save 15% off. - BrainTap | Go to http://braintap.com/dave to get $100 off the BrainTap Power Bundle. Resources: • Get My 2026 Biohacking Trends Report: https://daveasprey.com/2026-biohacking-trends-report/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ • Upgrade Labs: https://upgradelabs.com Timestamps: 0:00 – Intro 0:19 – Story 1: Microplastics in Testicles 1:44 – Story 2: Fear of Aging Accelerates Aging 3:30 – Story 3: Retatrutide Weight Loss Drug 4:42 – Story 4: Sleep Predicts Disease Risk 6:34 – Story 5: High Altitude & Diabetes 7:57 – Story 6: Supplement Regulation Bill 9:16 – Weekly Summary 10:51 – Outro See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The Super Bowl came and went and Housewives nationwide had a lot to say, including Jill Zarin and Taylor Armstrong. Andy Cohen urged fans to call E! to complain but, in a move no one saw coming, Jill was immediately terminated. Today, we break down the aftermath of Jill's termination, the larger ramifications, the backtracking by several of her ex RHONY colleagues and last, but not least, the future of the show. Amanda Frances is not leaving RHOBH, is looking forward to her upcoming WWHL appearance and is diligently preparing for the reunion which will be filmed in a mere few weeks. Last, but not least, Lynne Curtin's daughter Alexa, has surfaced revealing severe issues with drugs, homelessness loss of limbs and so much more.  @behindvelvetrope @davidyontef BONUS & AD FREE EPISODES Available at - www.patreon.com/behindthevelvetrope  BROUGHT TO YOU BY: CHEERS -CheersHealth.com (Get 20% Off A Way To Feel Better The Morning After A Few Drinks With Code Velvet ) COYUCHI - coyuchi.com/VELVETROPE (15% Off Your First Order Of The Most Comfortable Organic Sheets) MOOD - www.mood.com/velvet (20% Off With Code Velvet on Federally Legal THC Shipped Right To Your Door) ADVERTISING INQUIRIES - Please contact David@advertising-execs.com MERCH Available at - https://www.teepublic.com/stores/behind-the-velvet-rope?ref_id=13198 Learn more about your ad choices. Visit megaphone.fm/adchoices